Hospitals, vendors question FDA's plan to oversee decision-support software
from Modern Healthcare
The U.S. Food and Drug Administration's latest plan for overseeing clinical decision-support software leaves too much room for interpretation over what types of software the agency intends to regulate, according to health systems and software vendors. While stakeholders largely applauded the FDA's vision of a risk-based regulatory approach in theory, a major point of contention involves confusion over the FDA's definition of what software would be included under the FDA's oversight.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063